Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Shin, Kuwakado"'
Autor:
Masahiko Aoki, Ken Asaishi, Masahiro Goto, Kazuhide Higuchi, Toshifumi Yamaguchi, Hiroki Yukami, Shin Kuwakado, Tetsuji Terazawa, Takayuki Kii
Publikováno v:
Asia-Pacific journal of clinical oncologyREFERENCES. 15(5)
Aim Gastric cancer patients are normally treated with oral fluoropyrimidine and cisplatin or oxaliplatin; however, treating patients who also have a gastrointestinal obstruction is often difficult because of their poor oral intake. Instead, a modifie
Autor:
Yasunobu Ishizuka, Masahiro Goto, Toshifumi Yamaguchi, Takayuki Kii, Kazuhide Higuchi, Hiroki Yukami, Tetsuji Terazawa, Shin Kuwakado
Publikováno v:
Journal of Clinical Oncology. 37:83-83
83 Background: As a result of ATTRACTION2, nivolumab was added to the third line treatment in advanced gastric cancer (AGC), but the response rate was about 10%. As there is no predictive biomarker and no comparison with cytotoxic regimen, it is diff
Autor:
Motoki Yoshida, Masahiro Goto, Ken Asaishi, Shin Kuwakado, Kazuhide Higuchi, Hitoshi Nishitani, Takahiro Miyamoto, Shinichiro Kawabe, Takayuki Kii
Publikováno v:
Digestion. 87:59-64
Background/Aim: Combination chemotherapies of oxaliplatin or irinotecan with fluoropyrimidine and molecular target drug were reported to be active in several clinical studies and so regarded as a first-line standard therapy for unresectable or metast
Autor:
Hitoshi Nishitani, Takahiro Miyamoto, Tetsuji Terazawa, Takayuki Kii, Shin Kuwakado, Kazuhide Higuchi, Ken Asaishi, Masahiro Goto, Fukutaro Shimamoto
Publikováno v:
Internal medicine (Tokyo, Japan). 54(23)
Objective Recent guidelines have adopted an incidence of febrile neutropenia (FN) threshold of 20% for the use of prophylactic granulocyte colony-stimulating factor (G-CSF). In a Japanese phase II study of a combination chemotherapy regimen consistin
Autor:
Takayuki Kii, Ken Asaishi, Toshifumi Yamaguchi, Hiroyuki Kodama, Masahiro Goto, Kazuhide Higuchi, Hitoshi Nishitani, Shin Kuwakado, Tetsuji Terazawa, Fukutaro Shimamoto, Masahiko Aoki
Publikováno v:
Annals of Oncology. 28:x49
Autor:
Hitoshi Nishitani, Takayuki Kii, Ken-ichi Katsu, Masahiro Gotoh, Shinichiro Kawabe, Hiroya Takiuchi, Shin Kuwakado, Toshimitsu Tanaka, Shunsuke Ohta
Publikováno v:
Japanese Journal of Clinical Oncology. 37:583-589
Background: Recently, attention has been directed to concurrent chemoradiotherapy (CRT) for the treatment of squamous cell carcinoma of the esophagus with regard to efficacy, quality of life and functional preservation, and survival periods comparabl
Autor:
Fukutaro, Shimamoto, Takayuki, Kii, Masahiro, Goto, Shin, Kuwakado, Hitoshi, Nishitani, Tetsuji, Terazawa, Ken, Asaishi, Takahiro, Miyamoto, Yoshitaka, Kurisu, Kazuhide, Higuchi
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 42(8)
A 72-year-old previously healthy man visited our hospital with complaints of hoarseness and dysphagia. Computed tomography showed wall thickening of the thoracic esophagus; invasion to the left main bronchus, aorta, and right supraclavicular lymph no
Autor:
Hitoshi Nishitani, Makoto Sanomura, Takahiro Miyamoto, Tetsuji Terazawa, Takayuki Kii, Masahiro Goto, Ken Asaishi, Yukami Hiroki, Kazuhide Higuchi, Fukutaro Shimamoto, Shin Kuwakado
Publikováno v:
Journal of Clinical Oncology. 35:560-560
560 Background: Aprepitant (APR) showed the efficacy for the prevention of chemotherapy-induced nausea and vomiting (CINV) with highly emetogenic chemotherapy. The combination chemotherapies of moderately emetoegnic agents of oxaliplatin and irinotec
Autor:
Emi, Goto, Makoto, Hosomi, Masami, Nishihara, Masahiro, Goto, Motoki, Yoshida, Takayuki, Kii, Shin, Kuwakado, Hitoshi, Nishitani, Tomomi, Kawaharada, Hiroya, Takiuchi
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 39(13)
With the aging of society, the number of elderly patients receiving chemotherapy has increased. Since organ function, particularly the liver and kidney function, is known to decrease with age, there is concern that severe side effects may develop in
Autor:
Tetsuji Terazawa, Masahiro Goto, Takahiro Miyamoto, Ken Asaishi, Fukutaro Shimamoto, Shin Kuwakado, Hitoshi Nishitani, Takayuki Kii, Kazuhide Higuchi
Publikováno v:
Journal of Clinical Oncology. 34:e21600-e21600